Skip to content

Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)

A Safety and Feasibility Study of the Chartis System in Subjects With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00684892
Enrollment
25
Registered
2008-05-28
Start date
2008-05-31
Completion date
2008-11-30
Last updated
2009-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heterogeneous Emphysema

Keywords

Emphysema, Endobronchial Lung Volume Reduction

Brief summary

The purpose of this study is to evaluate the safety and feasibility of the Chartis System in measuring air flow and pressures in isolated lung compartments in emphysema patients prior to endobronchial lung volume reduction (ELVR).

Interventions

Assessment of airway flow and pressure

Sponsors

Pulmonx Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Heterogeneous emphysema as determined by high-resolution CT scan * Scheduled for clinically indicated ELVR procedure

Exclusion criteria

* Hyperexcretive chronic bronchitis or excessive sputum secretion * Active pulmonary infection * Active asthma or lung hyper-responsiveness

Design outcomes

Primary

MeasureTime frame
Adverse eventsUntil end of study procedure

Secondary

MeasureTime frame
Technical successDuring procedure and up 1 week post procedure

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026